Award
National Cancer Institute 5R01CA287734-02
Dissecting the role of B lineage cells in mediating response of resectable lung cancer to neoadjuvant immune-based therapy
Recipient
University of Texas MD Anderson Cancer Center
Award Amount
$670,358.00
Ceiling
$670,358.00
Awarded
July 30, 2025
Identifier
5R01CA287734-02
Research project funded by the National Cancer Institute to study B lineage cells' role in lung cancer response to immune therapy using clinical trials and advanced technologies.
Description
The project focuses on understanding the role of B lineage cells in lung cancer response to immune therapy. The project involves clinical trials, mouse models, and advanced sequencing technologies. It is funded by the NIH/NCI and involves collaboration with the University of Texas MD Anderson Cancer Center.